According to a recent study by the Cleveland Clinic published in the journal Arteriosclerosis Thrombosis and Vascular Biology, the use of erythritol, a common artificial sweetener, may be linked to a higher risk of cardiovascular events, like heart attacks and strokes. The study involved 20 participants who fasted overnight before having their blood sampled in the morning.

克利夫兰诊所最近在《动脉硬化血栓形成和血管生物学》杂志上发表的一项研究表明，使用赤藓糖醇（一种常见的人工甜味剂）可能会增加心脏病发作和中风等心血管事件的风险。这项研究涉及20名参与者，他们在早上采集血液样本之前禁食了一夜。

They were then given a beverage containing either 30 grams of erythritol or 30 grams of sugar, and their blood samples were taken again after 30 minutes. The results showed that erythritol levels in the bloodstream increased significantly after consuming the erythritol-laden drink, while blood glucose levels only slightly increased after the sugar-containing beverage.

然后给他们一种含有30克赤藓糖醇或30克糖的饮料，30分钟后再次采集血样。结果表明，饮用含赤藓糖醇的饮料后，血液中赤藓糖醇水平显着升高，而含糖饮料后血糖水平仅略有升高。

These findings suggested that erythritol consumption may increase platelet hyper-responsiveness, raising the risk of blood clot formation and potential cardiovascular problems. Stanley Hazen, the senior author of the study said, 'Many professional societies and clinicians routinely recommend that people at high cardiovascular risk—those with obesity, diabetes or metabolic syndrome—consume foods that contain sugar substitutes rather than sugar.

这些发现表明，赤藓糖醇的消耗可能会增加血小板的高反应性，增加血栓形成和潜在心血管问题的风险。该研究的资深作者斯坦利·哈森（StanleyHazen）说，“许多专业协会和临床医生经常建议心血管疾病高危人群——肥胖、糖尿病或代谢综合征患者——食用含有糖替代品而非糖的食物。

These findings underscore the importance of further long-term clinical studies to assess the cardiovascular safety of erythritol and other sugar substitutes.'He also recommended considering the occasional consumption of small amounts of sugar-sweetened treats over products sweetened with sugar alcohols, especially for individuals at higher risk of blood clot formation, such as those with heart disease, diabetes, or metabolic syndrome.

这些发现强调了进一步进行长期临床研究以评估赤藓糖醇和其他糖替代品的心血管安全性的重要性。”他还建议考虑偶尔食用少量含糖甜点而不是含糖醇的产品，特别是对于那些有较高血栓形成风险的人，如心脏病、糖尿病或代谢综合征患者。

This research is part of Hazen's broader investigation into the factors contributing to ongoing cardiovascular risk and the effects of common sugar substitutes. For .

这项研究是哈森对导致持续心血管风险的因素和常见糖替代品影响的更广泛调查的一部分。对于。

Biotech Stocks Facing FDA Decision In August 2024

2024年8月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In June 2024

2024年6月美国食品和药物管理局决定生物技术股

Biotech Stocks Facing FDA Decision In April 2024

2024年4月美国食品和药物管理局（FDA）决定生物技术股